Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Catherine Langham Insider Profile
4 Followers
Catherine Langham, Director at Eiger Biopharmaceuticals, holds 0.00 shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds 92.57K shares in Celadon Group (Ticker: CGIP), holds 0.00 shares in The Finish Line (Ticker: FINL). Most recently, Catherine Langham ― shares of Eiger Biopharmaceuticals on ― for an estimated value of ―.
Catherine Langham Eiger Biopharmaceuticals (EIGRQ)Director
Eiger Biopharmaceuticals (EIGRQ)
Director
Ranked #80,203 out of 98,042 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-26.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Catherine Langham holds in companies
Most Profitable Insider Trade
Stock:
The Finish Line
(FINL)
(FINL)
Rating:Informative Sell
Date:May 01, 2014 - May 01, 2015
Return:+9.80%
The most profitable trade made by Catherine Langham
Catherine Langham's Trading History
Eiger Biopharmaceuticals
―
Director
―
$0.00
Celadon Group
Dec 04, 2018
Director
Uninformative Buy
―
$1.20K
The Finish Line
Jun 18, 2018
―
Uninformative Sell
510.14K
$0.00
hhgregg
Aug 05, 2016
Director
Uninformative Buy
8.37K
$144.62
List of latest transactions for each holding click on a transaction to see Catherine Langham's performance on stock
You May Also Like
Catherine Langham insider profile FAQ
What is the percentage of profitable transactions made by Catherine Langham?
The percentage of profitable transactions made by Catherine Langham is 25%.
What is the average return per transaction made by Catherine Langham?
The average return per transaction made by Catherine Langham is -26.90%.
What stocks does Catherine Langham hold?
Catherine Langham holds: EIGRQ, CGIP, FINL, HGGG stocks.
What was Catherine Langham’s latest transaction?
Catherine Langham latest transaction was an Uninformative Buy of ―.
What was Catherine Langham's most profitable transaction?
Catherine Langham’s most profitable transaction was an Informative Sell of FINL stock on May 1, 2014. The return on the trade was 9.80%.
What is Catherine Langham's role in Eiger Biopharmaceuticals?
Catherine Langham's role in Eiger Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.